Valuation
- Market cap
- 164,143,000
- Revenue TTM
- $0
- Net income TTM
- $-35,920,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 700,900
- Avg volume
- 763,926
- Day's range
- $1.80 – $2.07
- Shares out
- 79,681,000
- Stochastic %K
- 63%
- Beta
- 1.49
- Analysts
- —
- Price target
- —
Company profile
Canton Strategic Holdings, Inc. focuses on advancing institutional blockchain adoption and digitizing financial markets in the United States. The company operates as a validator and super validator on the Canton Network, which provides validation and liveness services to the network. It also provides locking-as-a-service (LaaS) to Canton Network super validators and featured applications, which locks its own Canton C...
Show more
Canton Strategic Holdings, Inc. focuses on advancing institutional blockchain adoption and digitizing financial markets in the United States. The company operates as a validator and super validator on the Canton Network, which provides validation and liveness services to the network. It also provides locking-as-a-service (LaaS) to Canton Network super validators and featured applications, which locks its own Canton Coin (CC) on a customer's behalf while retaining legal and beneficial ownership. In addition, the company invests in the Canton ecosystem. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is based in New York, New York.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 212 210 6006
- Website
- https://www.cantonstrategic.com
- Address
- 1460 Broadway, New York, United States
Latest news
No headlines yet.
